Zoetis Inc (ZTS)
169.04
+0.91
(+0.54%)
USD |
NYSE |
May 10, 16:00
169.04
0.00 (0.00%)
After-Hours: 20:00
Zoetis Free Cash Flow (Quarterly): 455.00M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 455.00M |
December 31, 2023 | 699.00M |
September 30, 2023 | 579.00M |
June 30, 2023 | 17.00M |
March 31, 2023 | 326.00M |
December 31, 2022 | 570.00M |
September 30, 2022 | 372.00M |
June 30, 2022 | 190.00M |
March 31, 2022 | 194.00M |
December 31, 2021 | 511.00M |
September 30, 2021 | 534.00M |
June 30, 2021 | 368.00M |
March 31, 2021 | 323.00M |
December 31, 2020 | 566.00M |
September 30, 2020 | 445.00M |
June 30, 2020 | 348.00M |
March 31, 2020 | 314.00M |
December 31, 2019 | 416.00M |
September 30, 2019 | 378.00M |
June 30, 2019 | 215.00M |
March 31, 2019 | 326.00M |
December 31, 2018 | 446.00M |
September 30, 2018 | 476.00M |
June 30, 2018 | 194.00M |
March 31, 2018 | 336.00M |
Date | Value |
---|---|
December 31, 2017 | 525.00M |
September 30, 2017 | 391.00M |
June 30, 2017 | 129.00M |
March 31, 2017 | 77.00M |
December 31, 2016 | 226.00M |
September 30, 2016 | 182.00M |
June 30, 2016 | 83.00M |
March 31, 2016 | 6.00M |
December 31, 2015 | 197.00M |
September 30, 2015 | 152.00M |
June 30, 2015 | 76.00M |
March 31, 2015 | 15.00M |
December 31, 2014 | 336.00M |
September 30, 2014 | 61.00M |
June 30, 2014 | 102.00M |
March 31, 2014 | -68.00M |
December 31, 2013 | 249.00M |
September 30, 2013 | 59.00M |
June 30, 2013 | -70.00M |
March 31, 2013 | 259.00M |
December 31, 2012 | 265.00M |
September 30, 2012 | 48.00M |
June 30, 2012 | 50.00M |
March 31, 2012 | -35.00M |
December 31, 2011 | 60.00M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
17.00M
Minimum
Jun 2023
699.00M
Maximum
Dec 2023
391.00M
Average
375.00M
Median
Free Cash Flow (Quarterly) Benchmarks
Biogen Inc | 432.30M |
Pfizer Inc | 386.00M |
Eli Lilly and Co | 83.20M |
Bristol-Myers Squibb Co | 2.55B |
Amgen Inc | 459.00M |